Heterodimeric bispecific antibodies for highly specific treatment of EGFR(+)HER2(+) pancreatic ductal adenocarcinoma Meeting Abstract


Authors: Long, A. W.; Santich, B.; Guo, H.; Cheung, N. K.
Abstract Title: Heterodimeric bispecific antibodies for highly specific treatment of EGFR(+)HER2(+) pancreatic ductal adenocarcinoma
Meeting Title: AACR Special Conference: Pancreatic Cancer
Journal Title: Cancer Research
Volume: 82
Issue: 22 Suppl.
Meeting Dates: 2022 Sep 13-16
Meeting Location: Boston, MA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2022-11-15
Language: English
ACCESSION: WOS:000899825600160
PROVIDER: wos
DOI: 10.1158/1538-7445.PANCA22-C022
Notes: Meeting Abstract: C022 -- Located in the section "Immunobiology and Immunotherapy" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nai-Kong Cheung
    652 Cheung
  2. Hong-Fen Guo
    76 Guo
  3. Brian Horacio Santich
    18 Santich
  4. Alan Wyndham Long
    6 Long